ESR1 and ovarian carcinoma: However, another study showed that appropriate concentrations of CDCA and DCA can reduce ESR1 expression in ovarian cancer cells by almost 90% (Jin et al., 2018), indicating that CDCA may reduce proliferation by inhibiting ESR1 expression in ectopic endometrial cells through targeted effects.